Transaldolase Deficiency Deep Research Fallback

Date: 2026-05-05T07:40:18Z

Provider Attempts

• Falcon deep-research client was invoked directly with the disease pathophysiology template for Transaldolase deficiency (MONDO:0011624) and timed out after the bounded timeout interval with no usable report.
• Earlier just research-disorder falcon Transaldolase_Deficiency could not run before the YAML file existed.

Evidence Scope Used for Curation

Because the provider attempt did not return a usable artifact, curation proceeded from structured Orphanet ORPHA:101028 and cached literature references. The main evidence set used was:

• ORPHA:101028 for disease definition, inheritance, prevalence, TALDO1 gene association, MONDO/OMIM cross-references, and HPO phenotype frequency rows.
• PMID:23315216 for a 12-patient clinical series defining the multisystem phenotype and TALDO segregation.
• PMID:25388407 and PMID:24497183 for patient-level clinical variability, urinary polyol diagnostics, renal/cardiac/liver/skin features, and TALDO1 molecular confirmation.
• PMID:15115436 for the Ser171 deletion mechanism causing transaldolase inactivation and proteasome-mediated degradation in patient-derived cells.
• PMID:17613166 for pentose phosphate pathway redox biology and the hepatocyte cell-death/cirrhosis pathogenesis model.
• PMID:29923087 for acetaminophen sensitivity, diagnostic metabolomics, and N-acetylcysteine/acetaminophen-avoidance management implications.
• PMID:33159679 and PMID:38440129 for later endocrine presentations and the expanded multisystem clinical spectrum.

No uncached claims from the failed provider attempt were used.